Bei Wang 1 , Wen Xu 1 , Yuxuan Cai 1 , Chong Guo 1 , Gang Zhou 2 , Chengfu Yuan 1 Show Affiliations »
Abstract
BACKGROUND: CASC15, one of long non-coding RNA, is involved in the regulation of many tumor biological processes, and is expected to become a new biological therapeutic target. This paper aims to elucidate the pathophysiological function of CASC15 in various tumors. METHODS: The relationship between CASC15 and tumors was analyzed by searching references, and summarized the specific pathophysiological mechanism of CASC15. RESULTS: LncRNA CASC15 is closely related to tumor development, and has been shown to be abnormally high expressed in all kinds of tumors, including breast cancer, cervical cancer, lung cancer, hepatocellular carcinoma, gastric cancer, bladder cancer, colon cancer, colorectal cancer, cardiac hypertrophy, intrahepatic cholangiocarcinoma, leukemia, melanoma, tongue squamous cell carcinoma and nasopharyngeal carcinoma. However, CASC15 has been found to be down-expressed abnormally in ovarian cancer, glioma and neuroblastoma. Besides, it is identified that CASC15 can affect the proliferation, invasion and apoptosis of tumors. CONCLUSION: LncRNA CASC15 has the potential to become a new therapeutic target or marker for a variety of tumors. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
BACKGROUND: CASC15 , one of long non-coding RNA, is involved in the regulation of many tumor biological processes, and is expected to become a new biological therapeutic target. This paper aims to elucidate the pathophysiological function of CASC15 in various tumors . METHODS: The relationship between CASC15 and tumors was analyzed by searching references, and summarized the specific pathophysiological mechanism of CASC15 . RESULTS: LncRNA CASC15 is closely related to tumor development, and has been shown to be abnormally high expressed in all kinds of tumors , including breast cancer , cervical cancer , lung cancer , hepatocellular carcinoma , gastric cancer , bladder cancer , colon cancer , colorectal cancer , cardiac hypertrophy , intrahepatic cholangiocarcinoma , leukemia , melanoma , tongue squamous cell carcinoma and nasopharyngeal carcinoma . However, CASC15 has been found to be down-expressed abnormally in ovarian cancer , glioma and neuroblastoma . Besides, it is identified that CASC15 can affect the proliferation, invasion and apoptosis of tumors . CONCLUSION: LncRNA CASC15 has the potential to become a new therapeutic target or marker for a variety of tumors . Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Entities: Disease
Gene
Keywords:
CASC15; Long non-coding RNA; biomarker; malignancy; molecular mechanism; therapeutic target
Year: 2021
PMID： 32962611 DOI： 10.2174/1381612826666200922153701
Source DB: PubMed Journal: Curr Pharm Des ISSN： 1381-6128 Impact factor: 3.116